J Family Med Prim Care
October 2019
Background: To compare the efficacy and safety of intravenous levetiracetam and phenytoin in status epilepticus.
Methodology: A prospective, randomized controlled, nonblinded study was conducted in children 1 month to 12 years of age with active seizure and with status epilepticus. A total of 104 children were randomly allocated to either group 1 (levetiracetam) or group 2 (phenytoin) on the basis of computer-generated random number table.